Academics and clinicians met in Rome to present and debate evidence informing the optimisation of antithrombotic therapy for cardiovascular disease prevention (CVD).
The International Aspirin Foundation Conference will provide the scientific arena to enable this important discussion to take place within its two main sessions devoted to the assessment of benefits and risks of antithrombotic drugs in secondary and primary prevention settings, respectively.